Reports

Browse current and previous editions of Switzer Report

Thursday Edition, 24 April 2025
Paul Rickard

Questions of the Week

Paul Rickard · April 24, 2025

How can I protect my international shares against a rising Aussie dollar? Is Super Retail Group, which is paying a very attractive dividend, a “buy”? What do the brokers think of Technology One? Does the BOQ dividend reinvestment plan (DRP) issue shares at a discount?

Q&A Premium
Switzer on Saturday, 19 April 2025
Thursday Edition, 17 April 2025
Maureen Jordan

“HOT” stock: Lynas Rare Earths (LYC)

Maureen Jordan · April 17, 2025

In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, says that with China banning the exports of rare earths to the US, Lynas Rare Earths (LYC) is a buy again.

Investing Premium
Paul Rickard

Questions of the Week

Paul Rickard · April 17, 2025

Why is the rout in US Treasury Bonds impacting world markets? Why does RIO publish a quarterly production report? Do the brokers see more upside with MediBank Private? With oil stocks being slammed, is Woodside or Santos better value?

Q&A Premium
Monday Edition, 14 April 2025
Peter Switzer

I’ll buy these 6 stocks

Peter Switzer · April 14, 2025

You never want a serious crisis to go to waste so let me tell you the six quality stocks I’ll be buying as soon as I think ‘normalcy’ is back.

Investing Premium
Maureen Jordan

HOT” stock: Resmed (RMD)

Maureen Jordan · April 14, 2025

In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk, gives us a rundown on what tariffs apply to various pharma stocks and which pharma he sees as an ADD to an investor’s portfolio.

Investing Premium
James Dunn

Is CSL a buy?

James Dunn · April 14, 2025

The outlook for CSL (one of the few true global leaders on the ASX) from the analysts (who aren’t always right) is that the recent price decline gives investors an improved access point to a high-quality global healthcare exposure. Let’s put CSL under the microscope.

Investing Premium
Switzer on Saturday, 12 April 2025
Peter Switzer

Trump fought the war, and the markets won

Peter Switzer · April 12, 2025

It’s a good sign that Wall Street was able to finish on a positive note, with all four most-watched indexes (i.e. the Dow, S&P 500, Nasdaq and Russell 2000) all ending up over 1%

Switzer on Saturday Premium
Thursday Edition, 10 April 2025
Tony Featherstone

Three ETFs worth considering

Tony Featherstone · April 10, 2025

So far so good with the Trump U-turn on tariffs, but uncertainty still prevails. Is cautious buying to take advantage of lower valuations therefore warranted?

Investing Premium
1 44 45 46 47 48 124

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.